Skip to main content
Prevention and Management of Infectious Complications in Pediatric Patients With Cancer: A Survey Assessment of Current Practices Across Children's Oncology Group Institutions.
Effective Use of ALK Inhibitors in EML4::ALK-Positive Lymphatic Malformations.
Multilevel challenges to equitable inclusion of children in trials when parents use languages other than English: A qualitative report from Children's Oncology Group's Diversity and Health Disparities Committee Language Equity Working Group.
Time to diagnosis among young patients with cancer.
Long-term follow-up of patients with intermediate-risk neuroblastoma treated with response- and biology-based therapy: A report from the Children's Oncology Group study ANBL0531.
Treatment of relapsed/refractory severe aplastic anemia in children: Evidence-based recommendations.
Treatment of newly diagnosed severe aplastic anemia in children: Evidence-based recommendations.
Late cognitive and adaptive outcomes of patients with neuroblastoma-associated opsoclonus-myoclonus-ataxia-syndrome: A report from the Children's Oncology Group.
Desensitization using pegaspargase in the era of commercially available Erwinia: A single-institution report on efficacy, cost, and resource utilization.
Financial assistance and other financial coping strategies after a pediatric cancer diagnosis.